ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,441, issued on Sept. 30, was assigned to Janssen BioPharma Inc. (South San Francisco, Calif.).
"Modified nucleoside phosphoramidites" was invented by Sergei Gryaznov (San Mateo, Calif.), Jin Hong (Pacifica, Calif.), Vivek Kumar Rajwanshi (Cupertino, Calif.) and Leonid Beigelman (San Mateo, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds and compositions containing 5'-phosphoramidite nucleoside monomers, and methods of making and use."
The patent was filed on May 23, 2024, under Application No. 18/672,651.
*For further information, including images, charts and tables, please visit: http://patft.usp...